Angiotensin II
Established biology · indication-specific medicine.
THE SHORT VERSION
The role. The evidence. The limits.
48 concise guides, each with a one-page PDF. Start here, then follow the full evidence record for sources, review dates and context.
Established biology · indication-specific medicine.
Controlled human trials · larger obesity trial negative.
Observational preprint; controlled efficacy not established.
A natural signal—not a wellness treatment.
Approved human use · product-specific labels.
Investigational · human trials incomplete.
Established biology · indication-specific medicine.
Limited controlled human pharmacology.
Approved human use · product-specific labels.
Small controlled human study · weak findings.
In-vitro evidence; human claims remain unestablished.
Interesting skin-repair research. Unproven injection benefits.
Foundational biology · human evidence varies.
Approved human use · product-specific labels.
Approved human use · product-specific labels.
Limited human evidence.
Foundational biology · human evidence varies.
Animal research.
Approved human use · product-specific labels.
Approved human use · product-specific labels.
Approved human use · product-specific labels.
Controlled topical trial · no overall healing benefit.
Unapproved peptide · limited controlled evidence.
Human associations · treatment benefit unestablished.
Approved human use · product-specific labels.
Established biology · indication-specific medicine.
Investigational · not FDA-approved.
Approved human use · product-specific labels.
Investigational · controlled Phase 3 evidence.
Foundational biology · human evidence varies.
Controlled human evidence.
Approved human use · product-specific labels.
Controlled human evidence.
Historical approved uses; current products require separate evaluation.
Approved human use · product-specific labels.
Investigational · not FDA-approved.
Laboratory identification · therapeutic benefit unestablished.
Approved human use · product-specific labels.
Controlled human trials · results vary by indication.
Approved human use · product-specific labels.
Established biology · indication-specific medicine.
Established biology · indication-specific medicine.
Controlled phase 3 human evidence.
Combination: controlled human benefit not established.
Unsupported combination.
Unsupported combination.